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Abstract Endogenous antioxidants such as the lipid-soluble
vitamin E protect the cell membranes from oxidative damage.
Glutathione seems to be able to regenerate K-tocopherol via a
so-called free radical reductase. The transient protection by
reduced glutathione (GSH) against lipid peroxidation in control
liver microsomes is not observed in microsomes deficient in
K-tocopherol. Introduction of antioxidant flavonoids, such as 7-
monohydroxyethylrutoside, fisetin or naringenin, into the defi-
cient microsomes restored the GSH-dependent protection,
suggesting that flavonoids can take over the role of K-tocopherol
as a chain-breaking antioxidant in liver microsomal membranes.
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1. Introduction
Tissue damage due to an increased radical production has
been reported to play a role in a large number of (patho)-
physiological processes such as cancer, ageing, in£ammation
and ischemia^reperfusion. An important target of free radicals
appears to be the biomembrane. The radicals which are not
captured by the defence mechanism are able to induce lipid
peroxidation (LPO) in membranes. As a consequence of LPO,
membrane functions are inactivated: pores are formed in the
membrane [1], enzymes are inactivated and the membrane
£uidity is altered.
Endogenous antioxidants such as the lipid-soluble chain-
breaking antioxidant vitamin E (tocopherol) protect mem-
branes from this oxidative damage [2,3]. Vitamin E is a ge-
neric term used to collectively describe a range of tocopherol
and tocotrienol molecules. In vivo, K-tocopherol is the most
abundant and therefore the most important vitamer. It termi-
nates the chain reaction of LPO by scavenging lipid peroxyl
radicals (LOO). In this reaction, K-tocopherol itself becomes
a radical, but it is much less reactive than LOO [2].
Reduced glutathione (GSH) has also been shown to protect
against peroxidation of lipids in rat liver [4]. GSH seems to be
able to regenerate K-tocopherol from the tocopheroxyl radical
via a so-called free radical reductase, mainly present in the
liver [4^7]. This recycling process keeps the levels of K-toco-
pherol high enough to protect the membranes against LPO.
Recently, it has been shown that the anesthetic agent pro-
pofol (2,6-diisopropopylphenol), which like K-tocopherol con-
tains an aromatic hydroxyl (OH) group, was able to replace
K-tocopherol as an antioxidant [8]. Flavonoids which are a
class of naturally occurring compounds are known to be ex-
cellent antioxidants. They usually contain one or more aro-
matic hydroxyl groups and this moiety is, comparable to K-
tocopherol, responsible for the antioxidant activity of the £a-
vonoid. Based on this structural similarity, we hypothesized
that £avonoids might act similarly to K-tocopherol and could
mimic its antioxidant activity in the membrane. Therefore, we
investigated if also the £avonoids could replace K-tocopherol.
The hepatic microsomal free radical reductase system is very
well suited to test this hypothesis.
2. Materials and methods
2.1. Materials
7-Monohydroxyethylrutoside (monoHER) was kindly provided by
Novartis Consumer Health, Nyon, Switzerland. Naringenin (95%)
was obtained from Sigma Chemicals (St. Louis, MO, USA) and ¢setin
was purchased from Aldrich (Milwaukee, WI, USA). Vitamin E and
FeSO4 were obtained from Merck (Darmstadt, Germany). All other
chemicals were of the highest grade available.
2.2. Preparation of the microsomes
Male Wistar rats (200^220 g) obtained from Harlan Olac CPB
(Horst, The Netherlands) were killed by decapitation. Livers were
removed and homogenized in ice-cold phosphate bu¡er (50 mM phos-
phate+0.1 mM EDTA, pH 7.4, 1:2 w/v). The homogenate was cen-
trifuged at 10 000Ug (20 min at 4‡C). Subsequently, the supernatant
was centrifuged at 100 000Ug for 60 min (4‡C). The pellet was resus-
pended in phosphate bu¡er and centrifuged again at 100 000Ug
(60 min, 4‡C). Finally, the microsomal pellet was resuspended in
phosphate bu¡er (microsomes originating from 2 g liver/ml bu¡er)
and 1 ml aliquots were stored at 380‡C. Protein concentrations
were determined using the Bio-Rad Protein Assay (Bio-Rad Labora-
tories GmbH, Mu«nchen, Germany) with a bovine serum albumin
calibration curve.
2.3. Extraction of K-tocopherol
The stored microsomes were thawed and mixed with two volumes
of ice-cold acetone and shaken vigorously at 4‡C. After 5 min, the
microsomes were centrifuged for 15 min at 1500Ug (4‡C). The super-
natant was removed and the extraction was repeated two times. After
the third centrifugation step, the acetone was evaporated on ice under
an atmosphere of dry nitrogen. The pellet obtained after evaporation
was resuspended in 50 mM Tris^HCl bu¡er (pH 7.4, 37‡C) and
washed by centrifugation (45 min, 115 000Ug).
2.4. Preincubation with vitamin E or £avonoids
Stock solutions of the £avonoids were freshly prepared in nitrogen-
purged DMSO and nanopure water (1:1) just before use, as some of
the £avonoids tended to oxidize very quickly. The K-tocopherol-de¢-
cient microsomes were preincubated with 4.3 WM vitamin E or with
£avonoids using concentrations of approximately three times their
0014-5793 / 00 / $20.00 ß 2000 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 0 ) 0 1 5 1 7 - 9
*Corresponding author. Fax: (31)-20-4443844.
E-mail: f.vanacker@azvu.nl
FEBS 23650 8-5-00
FEBS 23650 FEBS Letters 473 (2000) 145^148
IC50 values of LPO inhibition, i.e. 30.6 WM monoHER, 1.5 WM ¢setin
or 2.7 mM naringenin. The mixture was shaken vigorously at 4‡C for
5 min. Subsequently, the microsomes were washed once by centrifu-
gation.
2.5. LPO assay
Microsomes (originating from 0.5 g liver/ml) were incubated at
37‡C, with shaking, and oxygen was freely admitted in Tris^HCl
(50 mM, pH 7.4). All compounds were added on ice, after which
the incubates were transferred to a water bath (37‡C), where 200 WM
ascorbate was added. The reaction was started by adding 10 WM
freshly prepared FeSO4 in nitrogen-purged nanopure water. The max-
imum DMSO concentration in the ¢nal incubation mixture was 2.5%,
which was found to have no in£uence on the assay. LPO was assayed
by measuring thiobarbituric acid (TBA) reactive substances according
to Haenen et al. [6]. At t = 0, 5, 10, 15, 30, 45 and 60 min, a 0.3 ml
aliquot of the incubation mixture was mixed with 2 ml of an ice-cold
TBA^trichloroacetic acid^HCl^butylhydroxytoluene (BHT) solution
to stop the reaction. After heating (15 min, 80‡C) and centrifugation
(15 min), the absorbance at 535^600 nm was determined. The TBA^
trichloroacetic acid^HCl^BHT solution was prepared by dissolving
41.6 mg TBA/10 ml trichloroacetic acid (16.8% w/v in 0.125 N
HCl). 1 ml BHT (1.5 mg/ml ethanol) was added to 10 ml TBA^tri-
chloroacetic acid^HCl. The data are expressed as mean þ S.E.M.
(n = 4^5).
The IC50 was determined with heat-inactivated microsomes by mea-
suring the percentage of LPO inhibition at several concentrations and
calculating the concentration at which 50% inhibition was obtained.
The IC50 values were given as the mean of 3^5 independent experi-
ments.
2.6. Determination of K-tocopherol
To determine K-tocopherol, it was extracted from the membrane by
heptane according to the method of Burton et al. [9]. K-Tocopherol
was quanti¢ed using high performance liquid chromatography
(HPLC) (C18 nucleosil column, Chrompack, The Netherlands; eluted
with 98% methanol, £ow rate 0.6 ml/min) with £uorescence detection
(Vex 295 nm, Vem 340 nm).
2.7. Determination of £avonoids
To determine the £avonoids monoHER, naringenin and ¢setin,
they were extracted from the membrane using two volumes (v/v) of
acidic MeOH (20% (v/v) bu¡er containing 25 mM NaH2PO4, 25 mM
acetic acid and 90 WM EDTA (pH 3.33)+80% (v/v) methanol). After
centrifugation (3 min, 1‡C), the supernatant was mixed with an equal
amount of 25 mM phosphate bu¡er (pH 3.33) containing 90 WM
EDTA. After a second centrifugation step (3 min, 1‡C), £avonoids
were quanti¢ed by a standard addition procedure using HPLC (YMC
ODS-AQ, 3 Wm, 150U4.6 mm, Bester, Amstelveen, The Netherlands;
eluted with 51 volumes 10 mM NaH2PO4+10 mM acetic acid+36 WM
EDTA and 49 volumes MeOH, £ow rate 0.7 ml/min) with electro-
chemical detection (Decade with glassy carbon working electrode set
at 0.7, 0.7 and 1.1 V vs. Ag/AgCl reference electrode for monoHER,
¢setin and naringenin, respectively).
3. Results
The IC50 values determined with heat-inactivated micro-
somes for naringenin, monoHER and ¢setin were 918 [10],
12.7 and 0.2 WM, respectively. GSH (1 mM) clearly protected
against LPO in control liver microsomes. After heating to
100‡C for at least 2 min to inactivate all enzymatic activity,
the GSH protection was completely abolished. After extrac-
tion with acetone, the K-tocopherol level dropped from
0.197 þ 0.005 nmol K-tocopherol/mg protein to a concentra-
tion of 0.022 þ 0.014 nmol/mg protein. In these K-tocopherol-
extracted microsomes, GSH (1 mM) could not protect against
LPO anymore, but after preincubation with K-tocopherol (4.3
WM), the protective e¡ect of GSH was restored (Fig. 1A). The
resulting membrane concentration was 4.62 þ 0.45 nmol/mg
protein (Table 1). When the K-tocopherol-de¢cient micro-
somes were preincubated with £avonoids using concentrations
of approximately three times their IC50 values of LPO inhibi-
tion, i.e. monoHER (30.6 WM), ¢setin (1.5 WM) or naringenin
(2.7 mM), these £avonoids mimicked the e¡ect of vitamin E
reintroduction (Fig. 1). The £avonoids themselves protected
already against LPO to a certain extent, but all three £avo-
noids showed a larger protection against LPO in combination
with GSH. Membrane concentrations of monoHER and nar-
ingenin were 3.8- and 325-fold higher than those obtained for
Fig. 1. Representative time-course of LPO in K-tocopherol-de¢cient microsomes in the presence (F) or absence (E) of GSH and (A) after prein-
cubation with vitamin E (4.3 WM) in the presence (b) or absence (a) of GSH, (B) after preincubation with monoHER (30.6 WM) in the pres-
ence (b) or absence (a) of GSH, (C) after the reintroduction of ¢setin (1.5 WM) in the presence (b) or absence (a) of GSH and (D) after the
introduction of naringenin (2.7 mM) in the presence (b) or absence (a) of GSH.
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vitamin E. Concentrations of ¢setin were however 5.6-fold
lower (Table 1).
4. Discussion
The protective e¡ect of GSH against Fe2/ascorbate-in-
duced LPO in liver microsomes depends on the presence of
K-tocopherol. We showed that in K-tocopherol-de¢cient mi-
crosomes, GSH did not protect against LPO which is in good
agreement with earlier ¢ndings [11]. Furthermore, after the
addition of K-tocopherol to these depleted microsomes, the
GSH-dependent protection was restored. The GSH-dependent
protection was completely lost in microsomes that were
heated (100‡C). This suggests that the GSH-dependent pro-
tection depends on a heat labile factor and it is therefore
assumed that this factor is the previously described free rad-
ical reductase [4^7].
The £avonoids chemically resemble the chain-breaking anti-
oxidant K-tocopherol, because they generally contain one or
more aromatic hydroxyl groups. These hydroxyl groups have
been shown to be important for the antioxidant activity of the
£avonoids [10,12^14] in the same way as for K-tocopherol [2].
We have shown that the introduction of the £avonoids
monoHER, ¢setin and naringenin into K-tocopherol-de¢cient
microsomes restores the GSH-dependent protection. This sug-
gests that £avonoids act similarly to and can take over the
role of K-tocopherol in the membranes. These results also
suggest that the free radical reductase is not speci¢c for K-
tocopherol, but also shows a⁄nity for other antioxidants such
as the £avonoids. This coincides with the e¡ects found for
propofol [8].
Although membrane concentrations of monoHER and nar-
ingenin are higher than the K-tocopherol concentration in
control microsomes (0.197 þ 0.005 nmol K-tocopherol/mg pro-
tein), the concentration of ¢setin is in the same order of mag-
nitude. These data suggest that ¢setin could take over the
antioxidant role of vitamin E with a similar potency. Narin-
genin is much less e⁄cient and very high plasma concentra-
tions would be needed to give an e¡ect. Although monoHER
is somewhat less e⁄cient than vitamin E, plasma levels equal
to the preincubation concentration of 30.6 WM, which would
be needed for the observed e¡ect, are easily obtained. After
administration of 500 mg/kg monoHER intraperitoneal to
mice, the peak plasma concentration reaches levels of approx-
imately 100 WM (personal communication, M.A.I. Abou El
Hassan, Department of Medical Oncology, University Hospi-
tal Vrije Universiteit). These concentrations clearly exceed the
concentration that is necessary for monoHER to take over the
role of K-tocopherol.
The concentrations of the £avonoids were added in the
same ratio as their IC50 values in LPO determined with
heat-inactivated control microsomes (0.2, 12.7 and 918 WM
for ¢setin, monoHER and naringenin, respectively). Assuming
that the GSH protection depends on the concentration of the
antioxidant would mean that ¢setin, with a membrane con-
centration of 0.83 nmol/mg protein, was the most potent com-
pound and that naringenin (1505 nmol/mg protein) was the
least potent. This potency correlates with the oxidation poten-
tial (Ep/2) of the compounds. Ep/2 values are 120 mV for
¢setin and 190 mV and 600 mV for monoHER and naringe-
nin, respectively [10]. However, although the Ep/2 value for K-
tocopherol is 859 mV [15], a membrane concentration of 4.62
nmol K-tocopherol/mg protein was su⁄cient to restore the
GSH-dependent protection, whereas for naringenin 1505
nmol/mg protein was needed. This suggests that other param-
eters such as binding to the free radical reductase or mem-
brane localization [16] probably also play a role. Taken to-
gether, a high Ep/2 value and a lower a⁄nity for the enzyme
or less favorable membrane localization might explain the low
potency of naringenin in restoring the GSH-dependent pro-
tection.
It is generally accepted that antioxidants co-operate and
that free electrons are transferred from one antioxidant to
another [17^20]. Flavonoids are excellent antioxidants and
therefore it is important to know their place in the antioxidant
network. In the present study, we have shown that there is an
interaction between £avonoids and glutathione. Moreover,
£avonoids can mimic the antioxidant activity of K-tocopherol
in the membrane. These properties might explain the bene¢-
cial e¡ect of £avonoids in for instance cardiovascular diseases
[21].
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